异环磷酰胺——当前状况与展望 - Suppr

Suppr

超能文献

Ifosfamide--current aspects and perspectives.

作者信息

Hilgard P, Herdrich K, Brade W

出版信息

Cancer Treat Rev. 1983 Sep;10 Suppl A:183-92. doi: 10.1016/s0305-7372(83)80027-9.

DOI:10.1016/s0305-7372(83)80027-9

PMID:6414693

Abstract

摘要

相似文献

Ifosfamide--current aspects and perspectives.异环磷酰胺——当前状况与展望

Cancer Treat Rev. 1983 Sep;10 Suppl A:183-92. doi: 10.1016/s0305-7372(83)80027-9.

Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.以异环磷酰胺作为单一药物及联合化疗治疗难治性恶性肿瘤。

Cancer Treat Rev. 1983 Sep;10 Suppl A:151-7. doi: 10.1016/s0305-7372(83)80021-8.

Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.阿霉素、异环磷酰胺和美司钠联合化疗治疗广泛期非小细胞支气管肺癌

Cancer Treat Rev. 1983 Sep;10 Suppl A:121-3. doi: 10.1016/s0305-7372(83)80016-4.

Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.美国正在进行的异环磷酰胺治疗儿童癌症的临床研究。

Semin Oncol. 1996 Jun;23(3 Suppl 6):84-90.

Continuously improving ifosfamide/mesna: a winning combination.不断改进的异环磷酰胺/美司钠：成功组合

Pediatr Blood Cancer. 2010 Oct;55(4):599-600. doi: 10.1002/pbc.22652.

Severe renal failure following high-dose ifosfamide and mesna.大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。

Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557).单剂量推注、分次注射或持续输注氮杂磷类药物（环磷酰胺、异环磷酰胺、Asta Z 7557）的治疗效果。

Cancer. 1984 Sep 15;54(6 Suppl):1193-203. doi: 10.1002/1097-0142(19840915)54:1+<1193::aid-cncr2820541317>3.0.co;2-z.

Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.2-巯基乙烷磺酸钠（美司钠）与异环磷酰胺的肾毒性。

Eur J Cancer Clin Oncol. 1984 Nov;20(11):1451-2. doi: 10.1016/0277-5379(84)90067-1.

Ifosfamide, mesna, and encephalopathy.异环磷酰胺、美司钠与脑病

Lancet. 1985 Jun 15;1(8442):1398-9.

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.使用异环磷酰胺输注联合美司钠进行大剂量烷基化疗法治疗成人晚期软组织肉瘤。

Cancer Chemother Pharmacol. 1983;11(2):69-72. doi: 10.1007/BF00254247.

引用本文的文献

EPIC: an effective low toxicity regimen for relapsing lymphoma.EPIC：一种用于复发性淋巴瘤的有效低毒性方案。

Br J Cancer. 1993 Sep;68(3):599-604. doi: 10.1038/bjc.1993.393.

A phase II study of ifosfamide in children with recurrent solid tumours.

Cancer Chemother Pharmacol. 1985;15(3):258-62. doi: 10.1007/BF00263897.

A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix.

Cancer Chemother Pharmacol. 1986;18(3):280-3. doi: 10.1007/BF00273403.

Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.

Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.大剂量异环磷酰胺治疗晚期非小细胞肺癌。

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S30-3. doi: 10.1007/BF00647448.

A phase II study of ifosfamide in paediatric solid tumours.

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S13-5. doi: 10.1007/BF00253231.

Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children.

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S2-6; discussion S7. doi: 10.1007/BF00253227.

Severe renal failure following high-dose ifosfamide and mesna.大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。

Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.

A phase II study of ifosfamide in endometrial cancer.异环磷酰胺治疗子宫内膜癌的II期研究。

Cancer Chemother Pharmacol. 1990;26 Suppl:S4-6. doi: 10.1007/BF00685407.

Chemotherapy for metastatic soft tissue sarcomas--another full circle?转移性软组织肉瘤的化疗——又回到原点了吗？

Br J Cancer. 1991 Jul;64(1):7-9. doi: 10.1038/bjc.1991.230.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验